Clinical Trials Logo
  1. Home
  2. Other
  3. NCT00614484

Chemotherapy and Proton Radiation for the Treatment of Locally Advanced Lung Cancer

Locally Advanced Non-Small Cell Lung Cancer Clinical Trial

Official title:
Phase I/II Study of Combined Chemotherapy and High Dose, Accelerated Proton Radiation for the Treatment of Locally Advanced Non-Small Cell Lung Carcinoma

Clinical Trial Summary

The purpose of this study is to determine the effectiveness of proton beam radiotherapy combined with chemotherapy for treatment of locally advanced non-small cell lung cancer.

Clinical Trial Description

n/a

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00614484
Study type Interventional
Source Loma Linda University
Contact
Status Terminated
Phase Phase 1/Phase 2
Start date August 1999
Completion date June 2011
View Details
See also
  Status Clinical Trial Phase
Completed NCT00702975 - Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic Therapy Phase 2
Recruiting NCT05339568 - Patient's Whole Process Follow-up Management(HOPE-1)
Recruiting NCT04749394 - A Study of Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy Phase 2
Recruiting NCT06287320 - The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer
Completed NCT01537991 - ISoToxic Accelerated RadioTherapy in Locally Advanced Non-small Cell Lung Cancer: The Phase I/II I-START Trial N/A
Completed NCT04648033 - Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC Phase 1
Completed NCT01059552 - Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Phase 1
Not yet recruiting NCT04153734 - Pembrolizumab + Platinum Doublets Without Radiation for Programmed Death-ligand 1 (PD-L1) ≥50% Locally Advanced NSCLC Phase 2
Completed NCT03371550 - A Phase II Trial of Cisplatin-Docetaxel Induction Plus Concurrent 3-D Conformal Radiotherapy and Weekly Chemotherapy Phase 2
Not yet recruiting NCT05620199 - Upfront Resection of Locally Advanced NSCLC Followed by Chemoradiotherapy N/A
Withdrawn NCT05481775 - Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer Phase 2